Learning Hub

< BACK Psoriatic Arthritis Awareness Day 2024 Sep 27, 2024 Advancing Psoriatic Arthritis Care with Technology and Research On 28 September, we celebrate Psoriatic Arthritis Awareness Day, a day dedicated to raising awareness about this condition and its impact on patients' lives. The iPROLEPSIS project is dedicated to improving our understanding and management of psoriatic arthritis. Did you know that psoriatic arthritis affects 112 out of 100,000 adults worldwide? This condition causes inflammation, pain, and fatigue, significantly affecting daily life. Therefore, finding better ways to monitor and manage it is important. PROLEPSIS-PDPID Study The iPROLEPSIS-PDPID study focuses on using smart devices and clinical data to develop new AI-driven models for personalised monitoring and flare prediction. This innovative approach seeks to empower patients by providing them with the tools they need to understand their condition better. miPROLEPSIS App A digital tool designed to help patients in tracking their condition. By collecting data from smartphones and smartwatches, the app offers insights into disease triggers and prognosis. This personalised information can help patients manage their symptoms more effectively, leading to improved health outcomes. Collaborative Efforts Conducted across four countries - the Netherlands, UK, Portugal, and Greece - the iPROLEPSIS project brings together experts and patients to transform the care of psoriatic arthritis. Through collaboration, the project aims to develop innovative solutions that cater to the needs of patients, enhancing their quality of life. Join Us in Raising Awareness As we celebrate Psoriatic Arthritis Awareness Day, we invite you to join us in promoting better management and understanding of psoriatic arthritis. Together we can make a difference in the lives of those living with this condition. 1/1 PREVIOUS NEXT

< BACK Developing Exergames for Psoriatic Arthritis using Agile Storyboarding and Game Design Processes Jun 27, 2024 Enhancing Mobility and Quality of Life through Agile Co-Designed Exergames for Psoriatic Arthritis We are pleased to announce our latest study, "Developing Exergames for Psoriatic Arthritis using Agile Storyboarding and Game Design Processes", presented at PETRA 2024. This research, a part of the Horizon Europe iPROLEPSIS project, focuses on creating Exergames to improve physical activity and well-being for individuals with Psoriatic Arthritis. Abstract Serious Games (SGs) offer significant potential in healthcare for disease assessment and intervention, enhancing patients’ quality of life. Exercise SGs, or Exergames, promote physical activity and mobility in a gamified environment, encouraging tailored exercises based on individual abilities and needs. Here, within the Horizon Europe iPROLEPSIS project that targets Psoriatic Arthritis (PsA), we describe the design process of Exergames to address PsA symptoms, including morning stiffness, impaired finger/hand and wrist functionality, and motor asymmetry. From a methodological point of view, the storyboarding technique was adopted to facilitate the visualization of the proposed Exergame scenarios, including the graphical user interface, interactive game elements, narratives, characters, and contexts related to the PsA condition. This approach has been implemented within an agile game development methodology, which includes gathering feedback early on to iteratively refine both the game ideas and prototype. Informed by the results of the game design via two agile sessions incorporating 25 participants (PsA patients, clinicians, technology developers, facilitators/observers), the current efforts are focused on developing the game prototypes and corresponding mock-ups, preparing them for upcoming clinical validation trials. The Exergames development lays the groundwork for an innovative framework to improve gross and fine motor symptoms in PsA patients. This framework could inform healthcare providers and policymakers about its potential inclusion in routine PsA management. Read more: https://dl.acm.org/doi/10.1145/3652037.3663939 Developing Exergames for Psoriatic Arthritis using Agile .pdf Download PDF • 1.70MB 1/1 PREVIOUS NEXT

< BACK DHU extends Call for Twinnings Deadline until October 13! Sep 20, 2023 DigitalHealthUptake (DHU) project has extended the submission deadline of the twinning applications In a move that promises to fuel innovation and support the acceleration of digital health initiatives, we are thrilled to announce that our synergy partner project, the DigitalHealthUptake (DHU) project, has extended the submission deadline of the twinning applications until October 13, 2023. Why apply for the DHU Call for Twinnings? Participating in the DHU Call for Twinnings offers a multitude of advantages: Knowledge Exchange: Engage in fruitful knowledge sharing with fellow innovators, gaining fresh insights and perspectives. Access to Innovative Solutions: Unlock the door to cutting-edge digital health solutions that can revolutionise healthcare in Europe. Networking Opportunities: Connect with a diverse and influential network of industry experts, thought leaders, and change-makers. Funding for Transformation: Access financial support to implement transformative digital applications, accelerating progress and impact in the health and care domain. What types of twinnings are being funded? Citizen/patient-focused twinning topics: Digital tools to support health education (health literacy), digital health literacy mHealth systems, wearable devices for monitoring and prevention, alerts, reminders Digital tools to support patient feedback and reporting of outcomes and experiences Digital tools to support proactive prevention, self-management, homecare, telemonitoring Tele-mentoring/coaching, virtual consultations, virtual coach, personal assistant ICT supporting adherence to medication and care plans Robotics (e.g., companion robots) Use of digital therapeutics Tools and services supporting independent living, ambient assisted living technologies, telecare Care practitioner-focused twinning topics: Advanced digital tools to support Integrated Care, including integration of health and social care services Interoperable digital solutions to support person-centred and integrated care Regional and national Electronic Health Record (EHR) systems and ePrescription solutions enabling person-centred care Regional, national and local Electronic Integrated Care Record (EICR) systems, integration of EHR and social care records Digital shared care plans (e.g., support to multi-disciplinary team(s)) Decision support for multi-morbidity and polypharmacy management ICT support for management of frailty ICT support for falls prevention eLearning to support workforce development for person-centred integrated care Important links Ready to take the next step? Here are some crucial links you'll need: How to apply: Access the application form here . Q&A document: Got questions? Check our Q&A document for answers. Webinar recording: Missed our informative webinar on the call? No problem! You can watch the recording here. Don't miss out on this opportunity to accelerate digital health solutions in Europe. Apply now! News & Events iPROLEPSIS - events.png News & Events iPROLEPSIS - events.png 1/1 PREVIOUS NEXT

< BACK Fostering Synergy: iPROLEPSIS and DHU Partnership Aug 31, 2023 Exploring Collaboration and Synergies with Digital Health Uptake Project This week, we had a fantastic opportunity to connect with Anett Ruszanov, the representative of empirica, the coordinating organisation of the Digital Health Uptake (DHU) project. Our discussion focused on exploring collaboration and networking opportunities between iPROLEPSIS and DHU. The Digital Health Uptake (DHU) project, funded through the Digital Europe Programme, is dedicated to aligning policies, strategies, instruments, and activities to promote the adoption of digital health solutions and services across Europe. DHU's efforts are categorized into three key aspects: RADAR, KNOWLEDGE COMMUNITY, and ACCELERATOR. During the conversation, Prof. Leontios Hadjileontiadis, iPROLEPSIS project coordinator, and Anett Ruszanov discussed possibilities for collaboration and synergies, such as mutual promotion of relevant news and events through websites, newsletters, and social media, as well as potential co-organisation of events. This dynamic conversation paved the way for the next steps in our partnership. We greatly appreciate this initiative and eagerly anticipate the next steps in our partnership! News & Events iPROLEPSIS - news.png News & Events iPROLEPSIS - news.png 1/1 PREVIOUS NEXT

< BACK Digital biomarkers for psoriatic arthritis: a qualitative focus group study on patient-perceived opportunities and barriers Oct 30, 2024 The qualitative study exploring the perspective of psoriatic arthritis (PsA) patients towards the digital biomarkers (dBMs) Latest research initiative under the iPROLEPSIS project: Digital biomarkers for psoriatic arthritis: a qualitative focus group study on patient-perceived opportunities and barriers Abstract Objectives The widespread adoption of wearables, for example, smartphones and smartwatches in the daily lives of the general population, allows passive monitoring of physiological and behavioural data in the real world. This qualitative study explores the perspective of psoriatic arthritis (PsA) patients towards these so-called digital biomarkers (dBMs). Methods As part of a Design Thinking approach, six focus groups were conducted involving 27 PsA patients. The semistructured topic guide included disease activity, coping strategies, care needs, and potential advantages and disadvantages of dBMs. Thematic analysis followed an abductive coding method. Results PsA daily permeates patients’ lives, both physically and mentally. Participants discussed how their lives are focused on minimising the impact of the disease on their daily routines. Their attempts to gain control over their disease highly depend on trial and error. Flare-ups are related to physiological as well as behavioural micro and macro changes. Understanding these changes could enable the detection of (early) flare. Participants elicited pros and cons of the use of dBMs, discussed their intended use and made practical remarks. This led to three main themes: ‘Perceived dBM opportunities’, ‘Mapping Disease activity’ and ‘Perceived dBM barriers and pitfalls’. Conclusion PsA patients are receptive to dBMs for tracking the disease symptoms. Disease activity is regarded multifaceted and thus, dBMs should include a broad range of features to truly reflect the disease activity status. Reducing the time of trial and error in learning to manage the disease is regarded beneficial. Establishing and maintaining the relationship with their attending physicians is a prerequisite, even if remote patient monitoring becomes an alternative for some physical hospital visits. Read the full publication in RMD Open: https://rmdopen.bmj.com/content/10/4/e004699 Digital biomarkers for psoriatic arthritis a qualitative focus groups study on patient-per .pdf Download PDF • 1.55MB 1/1 PREVIOUS NEXT

Learning Hub Explore resources to help you understand and manage psoriatic arthritis. Learning hub Key Facts Handbook News Feed Quizzes Search What is psoriatic arthritis? See related Handbook section PREVIOUS NEXT

Learning Hub Explore resources to help you understand and manage psoriatic arthritis. Learning hub Key Facts Handbook News Feed Quizzes Search How is psoriatic arthritis treated? Non-pharmacological treatments See related Handbook section PREVIOUS NEXT

< BACK iPROLEPSIS Presented at Health Data Summit 2025 Mar 27, 2025 Showcasing practical strategies for high-quality data mapping and harmonisation At Health Data Summit 2025 , organised by the European Institute for Innovation Through Health Data (i~HD) on March 18–19 in Brussels , the iPROLEPSIS project was presented by Thanos Vidakis from AINIGMA Technologies . The presentation was part of the session titled: "Advanced Strategies and Tools for Ensuring High-Quality Data During Data Mapping". It focused on how iPROLEPSIS uses the OMOP Common Data Model (CDM) and OHDSI tools to harmonize health datasets from various sources. By applying coding standards such as SNOMED , the project ensures consistency and interoperability across data systems. The talk also highlighted recent hands-on workshops with data experts , during which real-world data was mapped to the OMOP model and underwent quality checks . These steps are essential in delivering analytics-ready health data — a key goal of the project. iPROLEPSIS continues to support high standards in digital health research by promoting data quality, standardisation, and collaboration across partners. 1/2 PREVIOUS NEXT

< BACK Europe Day 2024 May 9, 2024 Celebrating Europe Day with iPROLEPSIS sister projects Happy Europe Day 2024! Today we celebrate unity in diversity, innovation and collaboration across the continent. As projects funded under the same Horizon Europe call topic: "Personalised blueprint of chronic inflammation in health-to-disease transition", we're proud to contribute to the common goals of understanding the risk factors that trigger the transition from health to disease, providing personalised prevention measures and reducing the burden of chronic diseases. Within iPROLEPSIS , we aim to develop a suite of digital health tools designed to detect early transitions to psoriatic arthritis, predict flares for timely intervention, and provide personalised recommendations and interventions for managing the disease. With our unique consortium of 15 partners from 9 countries, we are strengthening international and cross-border collaboration to advance research, technology and health progress in Europe and beyond. Join us in commemorating this special day by exploring the impactful work of our sister projects: GlycanTrigger , ENDOTARGET , IMMEDIATE , miGut-Health , AIDA EU project , PREVALUNG EU , PRAESIIDIUM , CARE-IN-HEALTH , Intercept-T2D , INITIALISE , Halt-RONIN , Together, we're shaping a brighter, more inclusive, and sustainable Europe through groundbreaking research and cross-border connections. Europe Day sister projects .png Europe Day sister projects .png 1/1 PREVIOUS NEXT

< BACK iPROLEPSIS Games Showcased at Lisboa Games Week 2025 Nov 24, 2025 The FMH/IST-ULisboa team presented the iPROLEPSIS Games, connecting with the gaming community and industry stakeholders The iPROLEPSIS Games were presented at Lisboa Games Week 2025 , held from 20–23 November in Portugal. The team from Faculdade de Motricidade Humana / Instituto Superior Técnico – ULisboa (Bárbara Ramalho, Samuel Gomes, Marta Vicente, Filipa Magalhães and Rodolfo Costa) showcased the serious games developed within the project. Lisboa Games Week is an event that reinforces the role of academic and professional training in the video game industry. Educational institutions present courses, projects, and programmes related to video game development, digital art, programming, design, animation, sound, virtual reality, artificial intelligence, and other technological and creative fields. The programme includes exhibitions, practical demonstrations, vocational guidance sessions, talks, and opportunities for direct contact with industry. Participation in this event provided a platform for presenting the iPROLEPSIS Games within a setting focused on education, creativity, and technological development. 🔗 https://lisboagamesweek.pt/ LGWPhoto4.jpeg LGWPhoto3.jpeg LGWPhoto3.jpeg LGWPhoto4.jpeg 1/4 PREVIOUS NEXT

< BACK Workshop at PETRA 2024: Advancing Personalised Health Through Multimodal Sensing and Innovative Environments Jan 25, 2024 Exploring the Future of Healthcare: AI-PROGNOSIS and iPROLEPSIS Projects Collaborate for Workshop on Human Health, Habits, and Behavior The workshop "AGENT - MultimodAl SiGnal Sensing/Analysis, Innovative Interactive Environments, and PersoNalized Behavioral Modeling for Improving QualiTy-of-Life" has been accepted in PETRA 2024! The workshop will be organised by the Centre for Research & Technology Hellas , Aristotle University of Thessaloniki , and Faculdade de Motricidade Humana in cooperation with the AI-PROGNOSIS and iPROLEPSIS projects. More info about the workshop: http://www.petrae.org/workshops/AGENT.html AI-PROGNOSIS is a Horizon Europe-funded project developing Artificial intelligence-based solutions for #Parkinson 's disease risk assessment and prognosis. iPROLEPSIS is a Horizon Europe-funded project developing a novel personalised digital care ecosystem for people with #Psoriatic #arthritis . The workshop aims to attract an interdisciplinary group of researchers involved in research related to early detection, assessment and monitoring of human health, habits and behaviour. The workshop will focus on novel technologies applied in real or virtual environments and aim to enhance the quality of daily living, especially for people with disabilities or patients suffering from chronic conditions. About PETRA 2024: PETRA (PErvasive Technologies Related to Assistive Environments) is a premier interdisciplinary conference focusing on computational and engineering approaches to enhance human performance and improve the quality of life. Join us in exploring the latest advancements in assistive technologies across various settings. More info: http://www.petrae.org/index.html Looking forward to an enriching exchange of ideas and knowledge at PETRA 2024! Banner1-2024.png Banner1-2024.png 1/1 PREVIOUS NEXT

< BACK iPROLEPSIS Project Presented to Sonova International Sep 10, 2024 Innovative Approaches in Digital Biomarkers In September 2024, the iPROLEPSIS project was presented at a meeting with Sonova International. This event included a series of insightful presentations, highlighting the project's focus on developing digital biomarkers. The iPROLEPSIS concept and vision were shared, showcasing the innovative approaches the project is undertaking. We extend our gratitude for the engaging discussions during the “Sonova-AUTH Day,” hosted by the Signal Processing & Biomedical Technology Unit at Aristotle University of Thessaloniki. The event featured a range of topics, including advancements in digital biomarkers, innovations in hearing instruments by Sonova Group, ear-EEG technology, auditory processing disorders, and insights into the hearing aid market in Greece. 1/2 PREVIOUS NEXT